Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase NA 16Phase 4 16Phase 3 9Phase EARLY_PHASE1 4Phase 2/3 3Phase 1 3Phase 1/2 2

Status

Completed 5Unknown 3Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Polycystic Ovary Syndrome 1Endometrial Adenocarcinoma 1Diabetes, Gestational 1Diabetes Mellitus 1Breast Neoplasms 1

Interventions

Cisplatin 20Docetaxel 19Capecitabine 19Oxaliplatin 14Drug Therapy 14Cyclophosphamide 14Paclitaxel 13Fluorouracil 12Radiotherapy 11apatinib 9Gemcitabine 9Doxorubicin 9Decitabine 9Methotrexate 8Epirubicin 8Carboplatin 8sintilimab 6Etoposide 6camrelizumab 5anlotinib 5XELOX 5Sorafenib 5Radiation 5Pemetrexed 5Neoadjuvant Therapy 5Leucovorin 5Idarubicin 5Dexamethasone 5Cytarabine 5Busulfan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Unknown × Metformin × Clear all
NCT02065687 2021-09-30

Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer

GOG Foundation

Phase 2/3 Unknown
469 enrolled 16 charts
Gynecologic

Endometrial Adenocarcinoma

NCT04387630 2020-06-11

Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer.

Mansoura University

Phase 2/3 Unknown
120 enrolled
Breast

Breast Neoplasms

NCT02802215 2016-06-16

MGDPCOS

Ain Shams University

Phase 2/3 Unknown
80 enrolled

Diabetes Mellitus, Polycystic Ovary Syndrome, Diabetes, Gestational

Data powered by HemOnc (CC BY 4.0) Colophon âš¡